Here's the live share price of Symbiotec Pharmalab along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Symbiotec Pharmalab | 0.18 | -1.37 | -1.37 | -1.37 | -1.37 | -0.46 | -0.28 |
| Sun Pharmaceutical Industries | -3.37 | -5.17 | 1.54 | 0.55 | 13.53 | 17.02 | 18.66 |
| Divi's Laboratories | 0.99 | 7.55 | 38.55 | 46.42 | 52.49 | 34.40 | 12.56 |
| Torrent Pharmaceuticals | 0 | -0.82 | 6.01 | 9.12 | 36.00 | 37.70 | 25.43 |
| Zydus Lifesciences | -1.96 | -8.72 | -0.48 | 19.91 | 5.18 | 20.53 | 14.62 |
| Cipla | -1.73 | -6.88 | -2.00 | 2.70 | -13.52 | 3.17 | 7.45 |
| Laurus Labs | 4.51 | 4.45 | 37.94 | 83.87 | 114.66 | 71.05 | 24.38 |
| Aurobindo Pharma | 0.70 | 0 | 13.09 | 26.77 | 52.10 | 24.09 | 17.74 |
| Dr. Reddy's Laboratories | -0.37 | -4.10 | -9.75 | -12.82 | -12.66 | 0.42 | 3.11 |
| Mankind Pharma | -1.71 | -5.61 | -3.82 | 3.64 | -11.29 | 8.68 | 9.95 |
| Lupin | -2.64 | -9.24 | -10.35 | -12.79 | 0.62 | 21.77 | 15.87 |
| Glenmark Pharmaceuticals | -2.15 | 4.52 | 9.28 | 5.17 | 11.46 | 42.89 | 35.55 |
| Biocon | -4.09 | -11.13 | -8.97 | -2.98 | 4.35 | 12.58 | 1.51 |
| Alkem Laboratories | -0.71 | -5.76 | -2.66 | -5.37 | -5.36 | 12.35 | 6.12 |
| Abbott India | -0.04 | -7.40 | -0.80 | -2.37 | -15.83 | 4.43 | 4.00 |
| Anthem Biosciences | 0.87 | 7.30 | 19.45 | 47.13 | 13.04 | 8.85 | 5.22 |
| Ipca Laboratories | -1.68 | 9.36 | 21.83 | 23.88 | 46.95 | 29.16 | 8.29 |
| GlaxoSmithKline Pharmaceuticals | -4.81 | 7.51 | 32.80 | 12.47 | 1.49 | 24.36 | 12.85 |
| Gland Pharma | -2.44 | -1.17 | 26.53 | 72.71 | 41.57 | 20.09 | -5.57 |
| Ajanta Pharma | 1.14 | -1.09 | 11.98 | 12.23 | 35.89 | 26.86 | 19.76 |
Source: Dion Global
Over the last one year, Symbiotec Pharmalab has declined 1.37% compared to peers like Sun Pharmaceutical Industries (13.53%), Divi's Laboratories (52.49%), Torrent Pharmaceuticals (36.00%). From a 5 year perspective, Symbiotec Pharmalab has underperformed peers relative to Sun Pharmaceutical Industries (18.66%) and Divi's Laboratories (12.56%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,109.08 | 1,121.9 |
| 10 | 881.03 | 0 |
| 20 | 440.52 | 0 |
| 50 | 176.21 | 0 |
| 100 | 88.1 | 0 |
| 200 | 44.05 | 0 |
Source: Dion Global
Date Time | Announcement |
|---|---|
| Sep 11, 2026, 09:48 PM IST IST | Symbiotec Pharmalab - Board Meeting Intimation for Prior Intimation Of The Meeting Of The Board Of Directors Of Symbiotec Pha |
| Sep 03, 2026, 07:18 PM IST IST | Symbiotec Pharmalab - Update On Intimation Under Regulation 8(2) Of The Securities And Exchange Board Of India (Prohibition O |
| Sep 01, 2026, 09:12 PM IST IST | Symbiotec Pharmalab - Intimation Under Regulation 8(2) Of The Securities And Exchange Board Of India (Prohibition Of Insider |
| Sep 01, 2026, 09:04 PM IST IST | Symbiotec Pharmalab - Disclosure Under Regulation 30(5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations |
| Sep 01, 2026, 01:48 PM IST IST | Symbiotec Pharmalab - Listing of Equity Shares of Symbiotec Pharmalab Ltd |
Source: Dion Global
Symbiotec Pharmalab Ltd. is a Public Limited Listed company incorporated on 20/09/2002 and has its registered office in the State of Madhya Pradesh, India. Company's Corporate Identification Number(CIN) is U24232MP2002PLC015293 and registration number is 015293. Currently Company is involved in the business activities of Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 563.59 Cr. and Equity Capital is Rs. 10.94 Cr. for the Year ended 31/03/2023.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Symbiotec Pharmalab is ₹1,036.50 as on Sep 16, 2026.
The Symbiotec Pharmalab is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Symbiotec Pharmalab is ₹6,945.44 Cr as on Sep 16, 2026.
Today’s highest and lowest price of Symbiotec Pharmalab are ₹1,088.80 and ₹1,034.35.
The 52-week high/low is the highest and lowest price at which Symbiotec Pharmalab stock has traded in the past 52-week or nearly a year. The 52-week high of Symbiotec Pharmalab is ₹1,193.90 and 52-week low of Symbiotec Pharmalab is ₹933.80 as on Sep 16, 2026.
The Symbiotec Pharmalab has shown returns of -3.62% over the past day, -4.94% for the past month, -4.94% over 3 months, -4.94% over 1 year, -1.54% across 3 years, and -0.93% over 5 years.
P/E ratio of and PB ratio of Symbiotec Pharmalab are 0.00 and 6.04 on Sep 16, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global